Life Science Company News

Reset
Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Enzymatica AB

FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Medivir AB

The Balance HealthCare Group expands luxury mental health and addiction services for UHNW individuals

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

PolyU forms global partnership with ZEISS Vision Care to expand impact and accelerate market penetration of patented myopia control technology

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Aquaporin raises DKK 172 million

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

Read more ››
By: GlobeNewswire - 25 Apr 2024

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Santhera Pharmaceuticals (Schweiz) AG

United Imaging Healthcare Strengthens Partnership with MedikaBazaar for Indian Market Leadership

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Ascentage Pharma

Invitae Enters into Agreement with Labcorp for Sale of Business

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Laboratory Corporation of America Holdings (LabCorp)

Labcorp Announces Winning Bid for Select Assets of Invitae

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Laboratory Corporation of America Holdings (LabCorp)

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Innovent Biologics (USA), Inc.

Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Nutriessential expands globally to Oceania, Asia and the Gulf

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Genomma Lab Internacional Announces Results for the First Quarter 2024

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Cytokinetics to Announce First Quarter Results on May 8, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cytokinetics, Inc.

Madrigal Statement on the Passing of Dr. Stephen Harrison

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Madrigal Pharmaceuticals, Inc.

Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Freeline Therapeutics Holdings plc | Freeline Therapeutics

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Kronos Bio, Inc.

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cidara Therapeutics, Inc.
Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »